1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, October 2016 (p20)

Biotechnology Analysis & Statistics in the United States, October 2016 (p20)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

All regions

571-600 of about 1800 reports

Purchase Reports From Reputable Market Research Publishers

Ubiquitin Enzymes: Key Targets and Future Market Potential, 2016-2030

Ubiquitin Enzymes: Key Targets and Future Market Potential, 2016-2030

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION The ubiquitin proteasome system (UPS) is one of the key protein degradation pathway involved in the control of protein homeostasis and turnover that mediates the regulation of several cellula ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Cardiac Marker Testing Market by Type, Product, Method, Disease, Testing - Global Forecast to 2021

Cardiac Marker Testing Market by Type, Product, Method, Disease, Testing - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global cardiac marker testing market is estimated to grow at a CAGR of 8.8% from 2016 to 2021 to reach USD 3.50 billion by 2021. Factors such as growing incidences of cardiovascular diseases, the rapidly ...

  • Industries : In Vitro Diagnostics, Medical Device
  • Countries : World, North America, United States
Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis

Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis

  • $ 125
  • Company report
  • October 2016
  • by GlobalData

Summary Canadean's "Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis

Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis

  • $ 125
  • Company report
  • October 2016
  • by GlobalData

Summary Canadean's "Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile ...

  • Countries : United States
Global Biotechnology - Industry Market Research Report

Global Biotechnology - Industry Market Research Report

  • $ 1020
  • Industry report
  • October 2016
  • by Ibisworld

Growing vitality: Industry operators will thrive as R&D funding rises alongside global demand for biotech products Abstract Global Biotechnology The Global Biotechnology industry comprises a diverse range ...

  • Industries : Biotechnology
  • Countries : World, United States
Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cytotoxic T Lymphocyte Protein 4 (Cytotoxic ...

  • Industries : Therapy, Oncology, Cancer
  • Countries : United States
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin ...

  • Industries : Therapy, Pharmaceutical, Biopharmaceutical, Pathology
  • Countries : World, Europe, United States
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) ...

  • Industries : Mental Health, Therapy, Biopharmaceutical, Pathology, Pharmaceutical
  • Countries : United States, World
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) ...

  • Industries : Pathology, Biological Therapy, Therapy, Cancer
  • Countries : United States
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Gastroenteritis - Pipeline Review, H2 2016

Gastroenteritis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Gastroenteritis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastroenteritis - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Pathology
  • Countries : United States
Banyan Biomarkers, Inc. - Medical Equipment - Deals and Alliances Profile

Banyan Biomarkers, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2016
  • by GlobalData

Summary Banyan Biomarkers, Inc. (Banyan Biomarkers) is a medical technology company that concentrates on research and development of in vitro diagnostic tests to detect traumatic brain injuries. The company ...

  • Industries : Genomics, Medical Device
  • Countries : United States
Biosearch Technologies, Inc. - Medical Equipment - Deals and Alliances Profile

Biosearch Technologies, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2016
  • by GlobalData

Summary Biosearch Technologies, Inc. (Biosearch), a subsidiary of LGC Limited is a biotechnology company that designs and manufactures regents. The company develops, and manufactures custom oligonucleotide-based ...

  • Industries : Genomics
  • Countries : United States
La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for La Jolla Pharmaceutical Company compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Pharmaceutical
  • Countries : United States, World
Vitae Pharmaceuticals Inc

Vitae Pharmaceuticals Inc

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Vitae Pharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Pharmaceutical
  • Countries : United States, World
Hepatitis D - Pipeline Review, H2 2016

Hepatitis D - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis D - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology
  • Countries : United States, World
Chikungunya Fever - Pipeline Review, H2 2016

Chikungunya Fever - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Chikungunya Fever - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chikungunya Fever - Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Xoma Corporation

Xoma Corporation

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Xoma Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : United States
Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline ...

  • Industries : Pathology, Cancer
  • Countries : World, Spain, United States
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsing Remitting Multiple Sclerosis ...

  • Industries : Pathology, Mental Health, Therapy
  • Countries : United States, Europe, World
C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Biological Therapy, Pathology
  • Countries : United States
Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycoprotein 41 (gp41) - Pipeline Review, H2 2016’, provides in depth analysis on Glycoprotein 41 (gp41) targeted ...

  • Industries : Pathology
  • Countries : United States
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) ...

  • Industries : Pathology, Biological Therapy, Therapy, Biotechnology
  • Countries : United States, World
UV/Visible Spectroscopy Market by Instrument Type, Application - Global Forecasts to 2021

UV/Visible Spectroscopy Market by Instrument Type, Application - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global UV/visible spectroscopy market is expected to reach USD 1,163.2 million in 2021 from USD 944.2 million in 2016 growing at a CAGR of 4.3%. Over the years, factors such as application of UV/visible ...

  • Countries : World, North America, United States
Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by GlobalData

Summary Provectus Biopharmaceuticals, Inc. (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States
Windtree Therapeutics Inc

Windtree Therapeutics Inc

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Windtree Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
  • Countries : United States
Fortress Biotech Inc

Fortress Biotech Inc

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Fortress Biotech Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biotechnology
  • Countries : United States, World
Stemcells, Inc.

Stemcells, Inc.

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Stemcells, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : United States

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.